1. Online Information on Antioxidants: Information Quality Indicators, Commercial Interests, and Ranking by Google
   Romaan Aslam et al, 2017, Front. Public Health CrossRef
2. A Promising Approach to Integrally Evaluate the Disease Outcome of Cerebral Ischemic Rats Based on Multiple-Biomarker Crosstalk
   Guimei Ran et al, 2017, Disease Markers CrossRef
3. Development of a novel oral delivery system of edaravone for enhancing bioavailability
   Ankit Parikh et al, 2016, International Journal of Pharmaceutics CrossRef
4. Neuroprotective effects of edaravone on cognitive deficit, oxidative stress and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in rats
   Shanshan Zhou et al, 2013, NeuroToxicology CrossRef
5. Edaravone (Radicut), a free radical scavenger, is a potentially useful addition to thrombolytic therapy in patients with acute ischemic stroke
   KIYOSHI KIKUCHI et al, 2013 CrossRef
6. The antioxidant edaravone prevents cardiac dysfunction by suppressing oxidative stress in type 1 diabetic rats and in high-glucose-induced injured H9c2 cardiomyoblasts
   Lei Ji et al, 2016, Can. J. Physiol. Pharmacol. CrossRef
7. Edaravone attenuates lipopolysaccharide-induced acute respiratory distress syndrome associated early pulmonary fibrosis via amelioration of oxidative stress and transforming growth factor-β1/Smad3 signaling
   Xida Wang et al, 2017, Biochemical and Biophysical Research Communications CrossRef
8. Edaravone, a Synthetic Free Radical Scavenger, Enhances Alteplase-Mediated Thrombolysis
   Kiyoshi Kikuchi et al, 2017, Oxidative Medicine and Cellular Longevity CrossRef
9. Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro/in vivo evaluation
   Ankit Parikh et al, 2017, Drug Delivery CrossRef
10. Clinical Neuroprotective Drugs for Treatment and Prevention of Stroke
    Kiyoshi Kikuchi et al, 2012, IJMS CrossRef
11. The Efficacy of Edaravone (Radicut), a Free Radical Scavenger, for Cardiovascular Disease
    Kiyoshi Kikuchi et al, 2013, IJMS CrossRef
12. Protective Role for Antioxidants in Acute Kidney Disease
    , 2017, Nutrients CrossRef
13. Edaravone, a Cytoprotective Drug, Enhances Transgene Expression Mediated by Lipoplexes in HepG2 Cells and Mice
    Shu Wang et al, 2018, International Journal of Pharmaceutics CrossRef
14. Evaluation of the in vivo antioxidative activity of redox nanoparticles by using a developing chicken egg as an alternative animal model
    Chiaki Abe et al, 2014, Journal of Controlled Release CrossRef
15. Bioavailability of Edaravone Sublingual Tablet Versus Intravenous Infusion in Healthy Male Volunteers
    Jiaqing Wang et al, 2018, Clinical Therapeutics CrossRef
16. null
    Masaharu Hayashi, 2019 CrossRef
17. Effect of edaravone against cisplatin-induced chronic renal injury.
    Natsumi Koike et al, 2021, Drug Chem Toxicol CrossRef
18. Retrospective study of clinical features and prognosis of edaravone in the treatment of paraquat poisoning
    Ren Yi et al, 2019, Medicine CrossRef
19. Edaravone cocrystals: synthesis, screening, and preliminary characterization
    Miroslav Veverka et al, 2013, Monatsh Chem CrossRef
20. Reduced Oxidative Stress in STEMI Patients Treated by Primary Percutaneous Coronary Intervention and with Antioxidant Therapy: A Systematic Review
    Sarah Ekeløf et al, 2014, Cardiovasc Drugs Ther CrossRef
21. Edaravone Mitigates Hexavalent Chromium-Induced Oxidative Stress and Depletion of Antioxidant Enzymes while Estrogen Restores Antioxidant Enzymes in the Rat Ovary in F1 Offspring1
    Jone A. Stanley et al, 2014 CrossRef
22. WITHDRAWN: Edaravone protects brain tissue from apoptosis and oxidative stress after acute carbon monoxide poisoning
    Qin Li et al, 2014, The American Journal of Emergency Medicine CrossRef
23. Edaravone attenuates brain damage in rats after acute CO poisoning through inhibiting apoptosis and oxidative stress
    Qin Li et al, 2016, Environ. Toxicol. CrossRef
24. Edaravone protects rats against oxidative stress and apoptosis in experimentally induced myocardial infarction: Biochemical and ultrastructural evidence
    Md Quamrul Hassan et al, 2015, Redox Report CrossRef
25. Edaravone protects osteoblastic cells from dexamethasone through inhibiting oxidative stress and mPTP opening
    Wen-xiao Sun et al, 2015, Mol Cell Biochem CrossRef
26. Edaravone abrogates LPS-induced behavioral anomalies, neuroinflammation and PARP-1
    Chandra Shaker Sriram et al, 2016, Physiology & Behavior CrossRef
27. Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis
    Yu-ichi Noto et al, 2016, Expert Review of Neurotherapeutics CrossRef
28. Streptozotocin inhibits synaptic transmission and edaravone attenuates streptozotocin-induced electrophysiological changes in CA1 pyramidal neurons of rat hippocampal slices
    Ting Ju et al, 2016, NeuroToxicology CrossRef
29. Edaravone and benidipine protect myocardial damage by regulating mitochondrial stress, apoptosis signalling and cardiac biomarkers against doxorubicin-induced cardiotoxicity
    Md Quamrul Hassan et al, 2019, Clinical and Experimental Hypertension CrossRef
30. Potential use of edaravone to reduce specific side effects of chemo-, radio- and immuno-therapy of cancers
    Christian Bailly, 2019, International Immunopharmacology CrossRef
31. Edaravone Attenuates Lung Injury in A Hind Limb Ischemia-Reperfusion Rat model: A Histological, Immunohistochemical and Biochemical Study
    Amira Adly Kassab et al, 2019, Annals of Anatomy - Anatomischer Anzeiger CrossRef
32. Edaravone reduces oxidative stress and intestinal cell apoptosis after burn through up-regulating miR-320 expression
    Jiaxiang Ke et al, 2019, Mol Med CrossRef
33. Predicting the Pharmacokinetic Characteristics of Edaravone Intravenous Injection and Sublingual Tablet Through Modeling and Simulation
    Xia Chen et al, 2020, Clinical Therapeutics CrossRef
34. Evaluation of the protective effect of edaravone on doxorubicin nephrotoxicity by [99mTc]DMSA renal scintigraphy and biochemical methods
    Fadime Demir et al, 2020, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
35. Chemical reactivity and uses of 1-phenyl-3-methyl-5-pyrazolone (PMP), also known as edaravone
    Christian Bailly et al, 2020, Bioorganic & Medicinal Chemistry CrossRef
36. Acetylated Polysaccharides From Pleurotus geesteranus Alleviate Lung Injury Via Regulating NF-κB Signal Pathway
    Xinling Song et al, 2020, IJMS CrossRef
37. Edaravone attenuates myocyte apoptosis through the JAK2/STAT3 pathway in acute myocardial infarction
    Hui Chen et al, 2020, Free Radical Research CrossRef
38. Edaravone: a potential treatment for the COVID-19-induced inflammatory syndrome?
    Sandra E. Reznik et al, 2020, Pharmacological Research CrossRef
39. Multiple biological active 4-aminopyrazoles containing trifluoromethyl and their 4-nitroso-precursors: synthesis and evaluation
    Yanina V. Burgart et al, 2020, European Journal of Medicinal Chemistry CrossRef
40. Mitigation of cholestasis-associated hepatic and renal injury by edaravone treatment: Evaluation of its effects on oxidative stress and mitochondrial function
    Mohammad Mehdi Ommati et al, 2020, Liver Research CrossRef
41. Evaluation of Edaravone effects on the differentiation of human adipose derived stem cells into oligodendrocyte cells in multiple sclerosis disease in rats
    Mohammad Bakhtiari et al, 2021, Life Sciences CrossRef
42. The effects of edaravone, a free‐radical scavenger in lung injury induced by valproic acid demonstrated via different biochemical parameters
    Bertan B. Bayrak et al, 2021, J Biochem Mol Toxicol CrossRef
43. Adjunctive cytoprotective therapies in acute ischemic stroke: a systematic review
    I. A. Mulder et al, 2021, Fluids Barriers CNS CrossRef
44. Influence of a Lipophilic Edaravone on Physical State and Activity of Antioxidant Liposomes: An Experimental and in silico Study
    Cristina Minnelli et al, 2021, Colloids and Surfaces B: Biointerfaces CrossRef
45. Oxidative stress and mitochondrial dysfunction following traumatic brain injury: From mechanistic view to targeted therapeutic opportunities
    Bahareh Hakiminia et al, 2022, Fundamemntal Clinical Pharma CrossRef
46. Evaluating the effect of Edaravone on clinical outcome of patients with severe COVID-19 admitted to ICU: a randomized clinical trial
    Mohammadreza Moslemi et al, 2022, Inflammopharmacol CrossRef
47. Synthesis of 4-Aminopyrazol-5-ols as Edaravone Analogs and Their Antioxidant Activity
    Yanina V. Burgart et al, 2022, Molecules CrossRef
48. Edaravone Improved Behavioral Abnormalities, Alleviated Oxidative Stress Inflammation, and Metabolic Homeostasis Pathways in Depression
    Sina Montazeri et al, 2023, Depression and Anxiety CrossRef
49. Repurposing of Various Current Medicines as Radioprotective Agents
    Rajwinder Kaur et al, 2023, ACAMC CrossRef
50. Antiviral Effect and Mechanism of Edaravone against Grouper Iridovirus Infection
    Jihui Kuang et al, 2023, Viruses CrossRef
51. Hybrids of selective COX-2 inhibitors and active derivatives of edaravone as COX-2 selective NSAIDs with free radical scavenging activity: Design, synthesis and biological activities
    Youzhi Wang et al, 2024, European Journal of Medicinal Chemistry CrossRef
52. Sorafenib and edaravone protect against renal fibrosis induced by unilateral ureteral obstruction via inhibition of oxidative stress, inflammation, and RIPK-3/MLKL pathway
    Mohamed A. Abou Taha et al, 2024, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
53. Edaravone combined with hyperbaric oxygen therapy in delayed encephalopathy after acute carbon monoxide poisoning: A meta-analysis
    Siyao Zeng et al, 2024, Journal of Clinical Neuroscience CrossRef